rs2066713

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_001045.6(SLC6A4):c.-220-1732C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.338 (AC=51,358) in the gnomAD database across 152,060 control chromosomes, including 9,252 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.389. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9252 hom., cov: 32)

Consequence

SLC6A4
NM_001045.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.966

Publications

64 publications found
Variant links:
Genes affected
SLC6A4 (HGNC:11050): (solute carrier family 6 member 4) This gene encodes an integral membrane protein that transports the neurotransmitter serotonin from synaptic spaces into presynaptic neurons. The encoded protein terminates the action of serotonin and recycles it in a sodium-dependent manner. This protein is a target of psychomotor stimulants, such as amphetamines and cocaine, and is a member of the sodium:neurotransmitter symporter family. A repeat length polymorphism in the promoter of this gene has been shown to affect the rate of serotonin uptake. There have been conflicting results in the literature about the possible effect, if any, that this polymorphism may play in behavior and depression. [provided by RefSeq, May 2019]
SLC6A4 Gene-Disease associations (from GenCC):
  • obsessive-compulsive disorder
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
  • autism spectrum disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001045.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.389 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001045.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

SLC6A4 NM_001045.6
MANE Select
HGVSc / HGVSpc.-220-1732C>T
Exon rankIntron 1 of 14
intron
Prot: NP_001036.1UniProt: P31645-1

Ensembl Transcripts

SLC6A4 ENST00000650711.1
MANE Select
HGVSc / HGVSpc.-220-1732C>T
Exon rankIntron 1 of 14
intron
Prot: ENSP00000498537.1UniProt: P31645-1
SLC6A4 ENST00000261707.7
TSL:1
HGVSc / HGVSpc.-220-1732C>T
Exon rankIntron 1 of 14
intron
Prot: ENSP00000261707.3UniProt: P31645-1
SLC6A4 ENST00000394821.2
TSL:1
HGVSc / HGVSpc.-220-1732C>T
Exon rankIntron 1 of 14
intron
Prot: ENSP00000378298.2UniProt: J3KPR9

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.338
AC:51314
Hom:9236
AN:151942
Cov:32
GnomAD4 genome
AF: 0.338
AC:51358
Hom:9252
AN:152060
Cov:32
TOPMed (Bravo)
AF: 0.323
AC:85563
Hom:14714
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.366
AC:245459
Hom:45928
AN:670578
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.341
AC:799
Hom:153
AN:2342
ChinaMAP Phase 1
AF: 0.0757
Denmark Genome
AF: 0.473
AC:142
AN:300
GenomeAsia100K
AF: 0.235
AC:817
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0700
AC:509
AN:7232
Qatari Genome
AF: 0.375
AC:66
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0720
AC:8837
Hom:326
AN:122674
Turkish Variome
AF: 0.291
AC:450
Hom:71
AN:1546
UK10K
AF: 0.399
AC:3014
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0883
AC:791
Hom:39
AN:8960
Showing 14 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign6.5
BayesDel_noAF
Benign-0.92
CADD
Benign0.72
DANN
Benign0.51
GPN-Star LLR
N/A0.041
GPN-Star score
N/A-0.041
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-0.97
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.